These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
791 related items for PubMed ID: 19631774
21. Consumption of yogurts fortified in vitamin D and calcium reduces serum parathyroid hormone and markers of bone resorption: a double-blind randomized controlled trial in institutionalized elderly women. Bonjour JP, Benoit V, Payen F, Kraenzlin M. J Clin Endocrinol Metab; 2013 Jul; 98(7):2915-21. PubMed ID: 23653431 [Abstract] [Full Text] [Related]
22. Vitamin D insufficiency in osteoporotic hip fracture patients: rapid substitution therapy with high dose oral cholecalciferol (vitamin D3). de Jong A, Woods K, Van Gestel L, Suresh M, Porteous M. Acta Orthop Belg; 2013 Oct; 79(5):578-86. PubMed ID: 24350522 [Abstract] [Full Text] [Related]
23. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. Lips P, Duong T, Oleksik A, Black D, Cummings S, Cox D, Nickelsen T. J Clin Endocrinol Metab; 2001 Mar; 86(3):1212-21. PubMed ID: 11238511 [Abstract] [Full Text] [Related]
24. Effects of Vitamin D Supplementation on Semen Quality, Reproductive Hormones, and Live Birth Rate: A Randomized Clinical Trial. Blomberg Jensen M, Lawaetz JG, Petersen JH, Juul A, Jørgensen N. J Clin Endocrinol Metab; 2018 Mar 01; 103(3):870-881. PubMed ID: 29126319 [Abstract] [Full Text] [Related]
25. Effects of vitamin D supplementation in older African American women. Gallagher JC, Peacock M, Yalamanchili V, Smith LM. J Clin Endocrinol Metab; 2013 Mar 01; 98(3):1137-46. PubMed ID: 23386641 [Abstract] [Full Text] [Related]
26. Fortified malted milk drinks containing low-dose ergocalciferol and cholecalciferol do not differ in their capacity to raise serum 25-hydroxyvitamin D concentrations in healthy men and women not exposed to UV-B. Fisk CM, Theobald HE, Sanders TA. J Nutr; 2012 Jul 01; 142(7):1286-90. PubMed ID: 22623396 [Abstract] [Full Text] [Related]
27. Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. Romagnoli E, Mascia ML, Cipriani C, Fassino V, Mazzei F, D'Erasmo E, Carnevale V, Scillitani A, Minisola S. J Clin Endocrinol Metab; 2008 Aug 01; 93(8):3015-20. PubMed ID: 18492750 [Abstract] [Full Text] [Related]
28. Renal function and 25-hydroxyvitamin D concentrations predict parathyroid hormone levels in renal transplant patients. Boudville NC, Hodsman AB. Nephrol Dial Transplant; 2006 Sep 01; 21(9):2621-4. PubMed ID: 16644777 [Abstract] [Full Text] [Related]
29. The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency. Leventis P, Kiely PD. Scand J Rheumatol; 2009 Sep 01; 38(2):149-53. PubMed ID: 18991184 [Abstract] [Full Text] [Related]
30. Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters. Matias PJ, Jorge C, Ferreira C, Borges M, Aires I, Amaral T, Gil C, Cortez J, Ferreira A. Clin J Am Soc Nephrol; 2010 May 01; 5(5):905-11. PubMed ID: 20203163 [Abstract] [Full Text] [Related]
31. Treatment of vitamin D deficiency: divergence between clinical practice and expert advice. Findlay M, Anderson J, Roberts S, Almond A, Isles C. Postgrad Med J; 2012 May 01; 88(1039):255-60. PubMed ID: 22362902 [Abstract] [Full Text] [Related]
32. Hip fracture risk in relation to vitamin D supplementation and serum 25-hydroxyvitamin D levels: a systematic review and meta-analysis of randomised controlled trials and observational studies. Lai JK, Lucas RM, Clements MS, Roddam AW, Banks E. BMC Public Health; 2010 Jun 11; 10():331. PubMed ID: 20540727 [Abstract] [Full Text] [Related]
36. Vitamin D deficiency and its correction in children with sickle cell anaemia. Wykes C, Arasaretnam A, O'Driscoll S, Farnham L, Moniz C, Rees DC. Ann Hematol; 2014 Dec 11; 93(12):2051-6. PubMed ID: 24981689 [Abstract] [Full Text] [Related]
37. Longevity of daily oral vitamin D3 supplementation: differences in 25OHD and 24,25(OH)2D observed 2 years after cessation of a 1-year randomised controlled trial (VICtORy RECALL). Macdonald HM, Gryka A, Tang JCY, Aucott LS, Fraser WD, Wood AD. Osteoporos Int; 2017 Dec 11; 28(12):3361-3372. PubMed ID: 28916992 [Abstract] [Full Text] [Related]
38. Ergocalciferol supplementation in children with CKD delays the onset of secondary hyperparathyroidism: a randomized trial. Shroff R, Wan M, Gullett A, Ledermann S, Shute R, Knott C, Wells D, Aitkenhead H, Manickavasagar B, van't Hoff W, Rees L. Clin J Am Soc Nephrol; 2012 Feb 11; 7(2):216-23. PubMed ID: 22266572 [Abstract] [Full Text] [Related]
39. Cholecalciferol, not ergocalciferol, should be used for vitamin D supplementation. Grant WB. Age Ageing; 2006 Nov 11; 35(6):645; author reply 645. PubMed ID: 16982666 [No Abstract] [Full Text] [Related]
40. Vitamin D supplementation in older people (VDOP): Study protocol for a randomised controlled intervention trial with monthly oral dosing with 12,000 IU, 24,000 IU or 48,000 IU of vitamin D₃. Schoenmakers I, Francis RM, McColl E, Chadwick T, Goldberg GR, Harle C, Yarnall A, Wilkinson J, Parker J, Prentice A, Aspray T. Trials; 2013 Sep 17; 14():299. PubMed ID: 24041337 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]